In the PANTS study, we showed that obesity, cigarette smoking, higher baseline markers of disease activity, anti‐TNF monotherapy and the development of antidrug antibodies are associated with low drug levels and anti‐TNF treatment failure.12 This evidence concerns the gene TNF and obesity due to melanocortin 4 receptor deficiency.